General
impact 16
Multicentre gene therapy for OTOF -related deafness followed up to 2.5 years
Multicentre gene therapy for OTOF -related deafness followed up to 2.5 years Nature, Published online: 22 April 2026; doi:10.1038/s41586-026-10393-y In a multicentre trial of AAV1-hOTOF gene therapy involving 42 partici…
Why it matters
Not an isolated event—multicentre has been trending in this direction. The gene connection makes it particularly relevant.